LMAT vs. ZBH
LMAT (LeMaitre Vascular, Inc.) and ZBH (Zimmer Biomet Holdings, Inc.) are both stocks. Both are in the Healthcare sector — LMAT in Medical Instruments & Supplies, ZBH in Medical Devices. Over the past 10 years, LMAT returned 20.44%/yr vs -2.15%/yr for ZBH. Their 0.25 correlation means their historical movements had little consistent relationship.
Performance
LMAT vs. ZBH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LMAT achieves a 25.53% return, which is significantly higher than ZBH's 5.02% return. Over the past 10 years, LMAT has outperformed ZBH with an annualized return of 20.44%, while ZBH has yielded a comparatively lower -2.15% annualized return.
LMAT
- 1D
- -0.85%
- 1M
- -1.52%
- 6M
- 19.81%
- YTD
- 25.53%
- 1Y
- 26.17%
- 3Y*
- 18.43%
- 5Y*
- 14.34%
- 10Y*
- 20.44%
- ALL TIME*
- 15.97%
ZBH
- 1D
- -1.08%
- 1M
- 7.39%
- 6M
- 8.46%
- YTD
- 5.02%
- 1Y
- 4.74%
- 3Y*
- -9.95%
- 5Y*
- -9.17%
- 10Y*
- -2.15%
- ALL TIME*
- 5.39%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $26.26M | $28.32M | $31.57M | |
| $205.34M | $207.14M | $199.64M |
LMAT vs. ZBH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
LMAT LeMaitre Vascular, Inc. | 25.53% | -10.95% | 63.63% | 24.60% | -7.40% | 25.10% | 14.09% | 53.77% | -25.13% | 26.58% |
ZBH Zimmer Biomet Holdings, Inc. | 5.02% | -14.03% | -12.46% | -3.81% | 4.24% | -17.02% | 3.77% | 45.37% | -13.30% | 17.86% |
Correlation
The correlation between LMAT and ZBH is 0.37, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.37 |
Correlation (3Y) Balances recent behavior with more history. | 0.36 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.41 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.37 |
Correlation (All Time) Calculated using the full available price history since Oct 19, 2006 | 0.25 |
The correlation between LMAT and ZBH shifts across timeframes, from 0.25 (all time) to 0.41 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
LMAT:
$2.32B
ZBH:
$18.17B
LMAT:
$2.66
ZBH:
$3.85
LMAT:
38.10
ZBH:
24.38
LMAT:
1.64
ZBH:
0.36
LMAT:
9.28
ZBH:
2.21
LMAT:
5.74
ZBH:
1.25
LMAT:
$256.28M
ZBH:
$8.41B
LMAT:
$185.52M
ZBH:
$5.89B
LMAT:
$90.48M
ZBH:
$2.21B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LMAT vs. ZBH — Risk / Return Rank
LMAT
ZBH
LMAT vs. ZBH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for LeMaitre Vascular, Inc. (LMAT) and Zimmer Biomet Holdings, Inc. (ZBH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| LMAT | ZBH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.57 | ||
| Sortino ratioReturn per unit of downside risk | +1.09 | ||
| Omega ratioGain probability vs. loss probability | 1.17 | 1.05 | +0.12 |
| Calmar ratioReturn relative to maximum drawdown | 1.07 | 0.14 | +0.93 |
| Martin ratioReturn relative to average drawdown | 2.07 | 0.25 | +1.81 |
Loading charts...
Drawdowns
LMAT vs. ZBH - Drawdown Comparison
The maximum LMAT drawdown since its inception was -75.69%, which is greater than ZBH's maximum drawdown of -65.03%. Use the drawdown chart below to compare losses from any high point for LMAT and ZBH.
Loading charts...
Drawdown Indicators
| LMAT | ZBH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -75.69% | -65.03% | -10.66% |
Max Drawdown (1Y)Largest decline over 1 year | -24.33% | -25.54% | +1.21% |
Max Drawdown (3Y)Largest decline over 3 years | -27.51% | -38.82% | +11.31% |
Max Drawdown (5Y)Largest decline over 5 years | -34.29% | -43.94% | +9.65% |
Max Drawdown (10Y)Largest decline over 10 years | -47.65% | -52.14% | +4.49% |
Current DrawdownCurrent decline from peak | -13.48% | -43.35% | +29.87% |
Average DrawdownAverage peak-to-trough decline | -18.94% | -20.21% | +1.27% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.56% | 14.17% | -1.61% |
Volatility
LMAT vs. ZBH - Volatility Comparison
LeMaitre Vascular, Inc. (LMAT) and Zimmer Biomet Holdings, Inc. (ZBH) have volatilities of 10.25% and 10.54%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LMAT | ZBH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.25% | 10.54% | -0.29% |
Volatility (6M)Calculated over the trailing 6-month period | 31.29% | 23.22% | +8.07% |
Volatility (1Y)Calculated over the trailing 1-year period | 38.18% | 32.47% | +5.71% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 36.45% | 27.10% | +9.35% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 41.29% | 28.66% | +12.63% |
Dividends
LMAT vs. ZBH - Dividend Comparison
LMAT's dividend yield for the trailing twelve months is around 0.89%, less than ZBH's 1.02% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LMAT LeMaitre Vascular, Inc. | 0.89% | 1.23% | 0.69% | 0.99% | 1.09% | 0.88% | 0.94% | 0.95% | 1.18% | 0.69% | 0.71% | 0.93% |
ZBH Zimmer Biomet Holdings, Inc. | 1.02% | 1.07% | 0.91% | 0.79% | 0.75% | 0.76% | 0.62% | 0.64% | 0.93% | 0.80% | 0.93% | 0.86% |
Financials
LMAT vs. ZBH - Financials Comparison
This section allows you to compare key financial metrics between LeMaitre Vascular, Inc. and Zimmer Biomet Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
LMAT vs. ZBH - Profitability Comparison
LMAT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, LeMaitre Vascular, Inc. reported a gross profit of 48.40M and revenue of 66.55M. Therefore, the gross margin over that period was 72.7%.
ZBH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Zimmer Biomet Holdings, Inc. reported a gross profit of 1.51B and revenue of 2.09B. Therefore, the gross margin over that period was 72.4%.
LMAT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, LeMaitre Vascular, Inc. reported an operating income of 17.78M and revenue of 66.55M, resulting in an operating margin of 26.7%.
ZBH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Zimmer Biomet Holdings, Inc. reported an operating income of 373.20M and revenue of 2.09B, resulting in an operating margin of 17.9%.
LMAT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, LeMaitre Vascular, Inc. reported a net income of 15.68M and revenue of 66.55M, resulting in a net margin of 23.6%.
ZBH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Zimmer Biomet Holdings, Inc. reported a net income of 238.10M and revenue of 2.09B, resulting in a net margin of 11.4%.
Frequently Asked Questions
LMAT and ZBH have a correlation of 0.37, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ZBH has higher volatility (10.54%) compared to LMAT (10.25%). In terms of maximum drawdown, LMAT dropped -75.69% vs ZBH's -65.03%.
LMAT currently has the higher Sharpe Ratio (0.68 vs 0.11), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LMAT and ZBH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer